AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metif-G 1 Tablet

Prescription Icon
Prescription Required

Marketer

Positif Life sciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Metif-G 1 Tablet

Gluco-Duo tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes. This dual-action formulation helps regulate blood glucose. Administer Gluco-Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continue treatment even with well-controlled blood sugar; abrupt cessation can elevate glucose levels, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication is one component of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your healthcare provider. Lifestyle modifications are crucial for diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize its symptoms (sweating, dizziness, headache, tremor) and manage them accordingly. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. Contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before initiating treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (complete blood count, liver function tests) are recommended.

Primary Ingredients of Metif-G 1 Tablet

There is no text provided to rephrase.

Uses of Metif-G 1 Tablet

Managing type 2 diabetes

Major Benefits of Metif-G 1 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take one Metif-G tablet with food.

Common Side effects of Metif-G 1 Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metif-G 1 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take one Metif-G tablet with a meal.

How Metif-G 1 Tablet works:

Metif-G 1 Tablet combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Metif-G 1 Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Metif-G 1 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingUNSAFE

Lactation and Metif-G 1 Tablet are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Metif-G 1 Tablet, potentially requiring dosage modification. Consult your physician for guidance. Metif-G 1 Tablet is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Metif-G 1 Tablet cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, Metif-G 1 Tablet should initially be prescribed at a low dose; it's contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Metif-G 1 Tablet :

Should you forget a Metif-G 1 Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metif-G 1 Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Metif-G 1 Tablet

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medicine safely and ensure it remains inaccessible to children, pets, and others.
Metif-G 1 Tablet can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). While rare, this harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Metif-G 1 Tablet and seek immediate medical attention.
Metif-G 1 Tablet combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Metif-G 1 Tablet may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use can result in vitamin B12 deficiency.
Prolonged Metif-G 1 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Metif-G 1 Tablet can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Metif-G 1 Tablet and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Metif-G 1 Tablet
35
MRP 40
12% off